InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
ANTX
Result 13 decisions over 120 months
Reset filters
Direction ?
Both13 Bought6 Sold7
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: ANTX Minimum: $1M
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
ANTX AN2 Therapeutics, Inc.
28 May 2025
Leonard Braden Michael
10% owner indirect
Sold at will 3×
2,300,000
$2.65M
43.3%
ANTX AN2 Therapeutics, Inc.
14 Aug 2024
Leonard Braden Michael
10% owner indirect
Bought
1,500,000
$1.56M
35.3%
ANTX AN2 Therapeutics, Inc.
9 Aug 2024
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Sold at will 2×
3,525,094
$3.81M
92.1%
ANTX AN2 Therapeutics, Inc.
18 Jan 2024
Zakrzewski Joseph S
Director indirect
Sold at will
100,000
$1.91M
19.8%
ANTX AN2 Therapeutics, Inc.
16 Jan 2024
Aziz Kabeer
Director indirect
Sold at will 2×
100,000
$1.97M
20.9%
ANTX AN2 Therapeutics, Inc.
16 Jan 2024
Adjuvant Global Health Technology Fund, L.P.
10% owner
Sold at will
84,093
$1.65M
4.0%
ANTX AN2 Therapeutics, Inc.
29 Sep 2023
Aziz Kabeer
Director indirect
Sold at will 2×
99,101
$1.61M
20.1%
ANTX AN2 Therapeutics, Inc.
29 Sep 2023
Adjuvant Global Health Technology Fund, L.P.
10% owner
Sold at will
83,337
$1.36M
3.8%
ANTX AN2 Therapeutics, Inc.
18 Aug 2023
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought
1,777,778
$16.00M
52.9%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
RA CAPITAL MANAGEMENT, L.P.
10% owner indirect
Bought 2×
1,666,666
$25.00M
105%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Adjuvant Global Health Technology Fund, L.P.
10% owner indirect
Bought
166,666
$2.50M
8.2%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Aziz Kabeer
Director indirect
Bought
166,666
$2.50M
8.2%
ANTX AN2 Therapeutics, Inc.
29 Mar 2022
Readnour Robin Shane
Director indirect
Bought 2×
153,334
$2.30M
45.9%
Showing 1–13 of 13.